NEW MEMBER SIGN UP
  Display Name
 
  Email Address
 
  Password
 
  Password again
 
  Zip
 
Country
 
   

Close Window

Privacy Statement
BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
     
Community Login

What is this?
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel Employers
 Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My eNewsletters

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

COMMUNITY
Login
Become a Member
Discussion Forums
FAQ

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

BIOTECH WORK PORTAL
Career Definitions
Labor Market Reports
Education & Training
Regions

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Resverlogix Corporation 

279 Midpark Way SE
Suite 202
Calgary  Alberta  T2X 1M2  Canada
Phone: 403-254-9252 Fax: 403-256-8495


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
Resverlogix Corporation (RVX.TO) Updates Shareholders on Accelerated Clinical Trial Plan 10/16/2009 9:05:59 AM    More...
Resverlogix Corporation (RVX.TO) Appoints A. Brad Cann as Chief Financial Officer 10/13/2009 8:13:02 AM    More...
Resverlogix Corporation (RVX.TO) RVX-208 Second Clinical Trial Demonstrates Success on Key Reverse Cholesterol Transport Markers 9/29/2009 9:00:51 AM    More...
Resverlogix Corporation (RVX.TO) Notice of Conference Call Webcast to Discuss Clinical Trial Data 9/25/2009 10:50:03 AM    More...
Resverlogix Corporation (RVX.TO) Phase 1b/2a Study Meets Primary Endpoint 8/25/2009 8:19:46 AM    More...
Resverlogix Corporation (RVX.TO)'s Success in Inflammation Program Results in 2 Patents Filed 5/19/2009 11:12:14 AM    More...
Resverlogix Corporation (RVX.TO) Provides Quarterly Update 4/28/2009 9:07:51 AM    More...
Resverlogix Corporation (RVX.TO) Board of Directors Update 11/26/2008 9:20:29 AM    More...
Resverlogix Corporation (RVX.TO) Release: RVX-208 Data Demonstrates Increase in Functional HDL Particles 11/10/2008 11:15:56 AM    More...
Resverlogix Corporation (RVX.TO) Release: RVX-208 Exploratory Study Illustrates Early Potential for Alzheimer's Disease 11/10/2008 9:54:39 AM    More...
123456789